Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Increlex mecasermin endocrine data

September 26, 2005 7:00 AM UTC

Data from 18 patients showed that once-daily dosing of Increlex was comparable to the approved twice-daily dosing. In the trial, 24-hour mean serum IGF-1 levels correlated to dose and the IGF binding ...